[The evidence-based invasive therapy of stable angina pectoris].
With the spread of invasive cardiology, and with the opening of new home centers today coronarography and the necessary coronary revascularization are accessible for everyone. The indication of invasive investigation of the acute coronary diseases (STEMI, NSTE-ACS) is crystallised by today. At the same time the indication that the invasive strategy of stable coronary disease depends on more factors, this is a complex exercise. This contains the clinical risk stratification (among the analysis of the classic risk factors), and measures the ejection fraction, and the result of the exercise test and the anatomically risk stratification - based on the coronarography. Authors summarised the clinical risk stratification and the indication of the invasive investigation of the stable coronary disease, based on the recent clinical trials and the guidelines.
Becker
Dávid
D
Semmelweis Egyetem, Altalános Orvostudományi Kar Kardiológiai Központ Budapest Városmajor u. 68. 1122. becdavid@gmail.com
Merkely
Béla
B
D000787:Angina Pectoris / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D017023:Coronary Angiography / Q000009:adverse effects; D001026:Coronary Artery Bypass; D023921:Coronary Stenosis / Q000150:complications* / Q000188:drug therapy / Q000628:therapy*; D003663:Decision Trees; D019317:Evidence-Based Medicine; D006801:Humans; D007391:International Cooperation; D008019:Life Style; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors
D002317:Cardiovascular Agents